Massive fetomaternal hemorrhage: clearance of fetal red blood cells after intravenous anti-D prophylaxis monitored by flow cytometry

Transfusion. 2008 Aug;48(8):1707-12. doi: 10.1111/j.1537-2995.2008.01740.x. Epub 2008 May 14.

Abstract

Background: The clearance of D+ red blood cells (RBCs) from the circulation in D- individuals mediated by passively administered anti-D occurs by opsonization with the antibody and subsequent removal in the spleen. Few data exist on the kinetics of clearance of large volumes of D+ RBCs from the maternal circulation by anti-D in clinical cases of massive fetomaternal hemorrhage (FMH).

Case report: A 33-year-old D- woman delivered a D+ female infant by emergency cesarean section for suspected fetal anemia. A massive FMH, initially estimated to be approximately 142 mL of RBCs, was found. In addition to the standard dose of intramuscular (IM) anti-D (300 microg) given immediately after delivery, 2700 microg of anti-D was administered intravenously (IV). The clearance of D+ fetal cells from the maternal circulation was monitored by flow cytometry in samples obtained on a daily basis using anti-D. The mother had no detectable anti-D 6 months after delivery.

Results: No clearance of fetal cells was apparent after the insufficient dose of IM anti-D. The IV administration of anti-D caused accelerated clearance of D+ fetal RBCs with a t1/2 of 24.5 hours. D+ reticulocytes comprised 4.2 percent of all D+ cells in the maternal circulation at delivery suggesting acute fetal blood loss.

Conclusions: The approach used in this report allowed a detailed analysis of the kinetics related to the clearance of fetal D+ RBCs. Simultaneous measurements of fetal reticulocytes and fetal RBCs in maternal blood may establish the timing of an FMH.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cesarean Section
  • Erythroblastosis, Fetal / blood
  • Erythroblastosis, Fetal / immunology
  • Female
  • Fetal Blood / cytology*
  • Fetomaternal Transfusion / blood*
  • Fetomaternal Transfusion / immunology*
  • Flow Cytometry / methods*
  • Humans
  • Infant, Newborn
  • Injections, Intravenous
  • Isoantibodies / administration & dosage*
  • Isoantibodies / blood
  • Isoantibodies / immunology
  • Pregnancy
  • Pregnancy Outcome
  • Reticulocytes / cytology
  • Rho(D) Immune Globulin
  • Spleen / cytology

Substances

  • Isoantibodies
  • RHO(D) antibody
  • Rho(D) Immune Globulin